Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sanofi - American Depositary Shares
(NQ:
SNY
)
41.82
+0.49 (+1.19%)
Streaming Delayed Price
Updated: 1:53 PM EDT, Jun 25, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,314,524
Open
41.50
Bid (Size)
41.82 (400)
Ask (Size)
41.83 (500)
Prev. Close
41.33
Today's Range
41.42 - 42.14
52wk Range
40.89 - 52.68
Shares Outstanding
1,250,690,553
Dividend Yield
5.79%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials
June 22, 2026
Via
Investor Brand Network
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
June 22, 2026
Via
Investor Brand Network
Performance
YTD
-13.3%
-13.3%
1 Month
-5.3%
-5.3%
3 Month
-9.1%
-9.1%
6 Month
-13.5%
-13.5%
1 Year
-13.6%
-13.6%
More News
Read More
Sanofi-ADR (NASDAQ:SNY): A High-Yield Dividend Stock with Strong Fundamentals
↗
June 16, 2026
Via
Chartmill
Recursion Pharmaceuticals Just Hit a 52-Week Low. Is This Former Nvidia Holding a Smart Buy Now?
↗
May 25, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
SANOFI-ADR (NASDAQ:SNY): A Quality Dividend Stock with a 5.31% Yield and Strong Fundamentals
↗
May 25, 2026
Via
Chartmill
Sanofi (NASDAQ:SNY) Emerges as a Decent Value Pick with Strong Fundamentals
↗
May 07, 2026
Via
Chartmill
Sanofi (NASDAQ:SNY): A High-Yield Dividend Stock with Strong Fundamentals and a 5.26% Payout
↗
May 02, 2026
Via
Chartmill
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
June 22, 2026
From
BioMedWire
Via
GlobeNewswire
1 Dirt Cheap Growth Stock to Buy Right Now
↗
May 18, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally
↗
May 13, 2026
Via
The Motley Fool
Is This Biotech Stock a Buy After a Groundbreaking Approval?
↗
May 08, 2026
Via
The Motley Fool
Recursion (RXRX) Q1 2026 Earnings Transcript
↗
May 07, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Blackstone's $400 Million Bet on Teva: What Does the Smart Money Know That Most Investors Don't?
↗
April 30, 2026
Via
The Motley Fool
Giants Costco, Sanofi, and SAP Raise Dividends by Over 10%
↗
April 28, 2026
Via
MarketBeat
3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery
↗
April 25, 2026
Via
The Motley Fool
Topics
Intellectual Property
World Trade
Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)
April 22, 2026
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Got $2,000? These Biotech Stocks Are Worth Considering for Long-Term Growth
↗
April 21, 2026
Via
The Motley Fool
Neurocrine Biosciences to Acquire Soleno Therapeutics in $2.9 Billion Deal as VYKAT™ XR Sales Soar
April 06, 2026
Via
MarketMinute
Topics
Intellectual Property
The "Liberation Day" Shockwave: US Finalizes 100% Tariffs on Branded Pharmaceutical Imports
April 06, 2026
Via
MarketMinute
Topics
Economy
World Trade
Trump Issues Landmark Executive Order: 100% Tariffs on Imported Patented Drugs to Force Onshoring
April 03, 2026
Via
MarketMinute
Topics
Economy
Government
Lawsuit
Gilead Sciences Acquires Ouro Medicines for $2.2 Billion to Lead 'Immune Reset' Revolution
March 31, 2026
Via
MarketMinute
Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability
March 31, 2026
Via
Finterra
Topics
Initial Public Offering
Eli Lilly Shares Slip Despite Positive Eczema Trial Results: Why the Market Reacted Coolly
March 27, 2026
Via
MarketMinute
AstraZeneca (AZN) Shares Rally After Breakthrough Chronic Lung Disease Trial Results
March 27, 2026
Via
MarketMinute
Topics
Intellectual Property
Sarepta Therapeutics (SRPT) Stock Surges 34.98% on Breakthrough Clinical Data
March 26, 2026
Via
MarketMinute
Frequently Asked Questions
Is Sanofi - American Depositary Shares publicly traded?
Yes, Sanofi - American Depositary Shares is publicly traded.
What exchange does Sanofi - American Depositary Shares trade on?
Sanofi - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Sanofi - American Depositary Shares?
The ticker symbol for Sanofi - American Depositary Shares is SNY on the Nasdaq Stock Market
What is the current price of Sanofi - American Depositary Shares?
The current price of Sanofi - American Depositary Shares is 41.82
When was Sanofi - American Depositary Shares last traded?
The last trade of Sanofi - American Depositary Shares was at 06/25/26 01:53 PM ET
What is the market capitalization of Sanofi - American Depositary Shares?
The market capitalization of Sanofi - American Depositary Shares is 52.30B
How many shares of Sanofi - American Depositary Shares are outstanding?
Sanofi - American Depositary Shares has 52B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
